We congratulate Sabine Flicker for successful evaluation of Qualification Agreement!

Sabine Flicker is the Head of Research Group “Antibody Research” at the Institute of Pathophysiology and Allergy Research, Center of Pathophysiology, Infectiology and Immunology, Medical University of Vienna where she and her team work on the molecular, immunological and structural characterization of allergen-specific antibodies and nanobodies to develop antibody/nanobody-based treatment and prevention strategies for allergy.

She studied biology, genetics, wrote her diploma thesis at the Department of Internal Medicine I at the Medical University of Vienna on tyrosine kinase signaling pathways in breast cancer cells and graduated from the Institute of Pathophysiology and Allergy Research in 2000. Her PhD thesis was already dedicated to the immunological characterisation of monoclonal allergen-specific human antibodies and their derivatives. Being fascinated by monoclonal antibodies and their various applications she decided to pursue her research on these impressive immunological weapons. The Hertha Firnberg postdoctoral program (FWF) designed to fund women starting out on their scientific careers facilitated her to explore the therapeutic potential of allergen-specific antibodies in experimental mouse models and offered a first important step towards clinical trials. Since her habilitation for Allergology she enjoys lecturing and supervising her PhD, Master and Bachelor students. She authored numerous publications on the role of antibodies in allergy, works as Associate Editor for „Frontiers in Allergy“ and „Scientific Reports” and is co-inventor of several patent applications.